Immunomodulation of TLR2 and TLR4 by G2013 (alfa-L-Guluronic acid) in CVID Patients
Laleh Sharifi(Tehran University of Medical Sciences), Abbas Mirshafiey(University of Mazandaran), Mona Moshiri(Tehran University of Medical Sciences), Farzaneh Towfighi Zavareh(Children's Medical Center), Monireh Mohsenzadegan(Children's Medical Center), Asghar Aghamohammadi(Amirkabir University of Technology), Gholamreza Azizi(Jefferson Hospital for Neuroscience), Anis Barati(Tehran University of Medical Sciences), Saied Bokaie(University of Tehran), Seyed Javad Sayedi(Mashhad University of Medical Sciences), Nima Rezaei(Education and Research Network)
Cited by 8
Related Papers
Interleukin-6 cytokine: An overview of the immune regulation, immune dysregulation, and therapeutic approach
|International Immunopharmacology|2022|384
Interleukin-18 cytokine in immunity, inflammation, and autoimmunity: Biological role in induction, regulation, and treatment
|Frontiers in Immunology|2022|363
Coronavirus disease 2019 (COVID‐19): An overview of the immunopathology, serological diagnosis and management
|Scandinavian Journal of Immunology|2020|339
The significant role of interleukin-6 and its signaling pathway in the immunopathogenesis and treatment of breast cancer
|Biomedicine & Pharmacotherapy|2018|312
Primary immunodeficiency and autoimmunity: A comprehensive review
|Journal of Autoimmunity|2019|239